The global coronary stents market size was estimated at USD 9.32 billion in 2022 and is expected to grow a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. Growing aging population and a rising prevalence of noncommunicable diseases such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period. According to the World Health Organization (WHO), in 2019, CVDs were among the major causes of mortality worldwide of which ischemic heart disease (IHD) ranks as the most prevalent. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of worldwide mortalities.

According to research published by the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 6,10,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the U.S. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period. Since a coronary stent is used in most of the Percutaneous Coronary Intervention (PCI) procedures.

Gather more insights about the market drivers, restrains and growth of the Global coronary stents market

Coronary Stents Market Segments Highlights:

• The Drug-Eluting Stents (DES) segment dominated the market for coronary stents and held the largest revenue share of 66.5% in 2022. The continued advancement and launch of new devices are important factors in strengthening DES's dominance as the preferred device for PCI procedures.
• The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
• The bare metal stents (BMS) segment is expected to have a steady growth rate over the coming year.
• Product launches, approvals, strategic acquisitions, and innovations are some of the crucial business strategies adopted by market participants to maintain and grow their global reach.
• North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.
• The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some the countries such as Australia and South Korea.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Ambient Assisted Living Market: The global ambient assisted living market size was valued at USD 7.36 billion in 2023 and is projected to grow at a CAGR of 26.8% from 2024 to 2030.
• Spinal Fusion Devices Market: The global spinal fusion devices market size was valued at USD 7.03 billion in 2023 and is projected to grow at a CAGR of 4.9% from 2024 to 2030.

Coronary Stents Market Segmentation

Grand View Research has segmented the global coronary stents market based on product, and region:

Coronary Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

• Bare Metal Stents (BMS)
• Drug-Eluting Stents (DES)
  • Biodegradable
  • Non-Biodegradable
• Bioresorbable Vascular Scaffold

Coronary Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Order a free sample PDF of the Coronary Stents Market Intelligence Study, published by Grand View Research.